New HPV vaccine could be even more effective at protecting against cervical cancer

New HPV vaccine could be even more effective at protecting against cervical cancer
(Image credit: iStock)

A new vaccine against human papillomavirus (HPV), which can cause cervical cancer, could be even more effective, according to research published in the journal Cancer Epidemology, Biomarkers, and Prevention.

The new vaccine, developed by drug maker Merck, will protect against nine strains of HPV and could be 90 percent effective. The current vaccine, GARDASIL, protects against four strains and is 70 percent effective.

Vaccination against these additional five types of HPV could be good news for women worldwide, as certain strains of HPV are more common outside of the United States and Europe — HPV 52 and 58, for example, are more common in Asia.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

The new vaccine is being reviewed by the FDA, and if it is approved, it could be available sometime in 2015, Time reports.

To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us